Victory Capital Management
WVE icon

Victory Capital Management’s Wave Life Sciences WVE Stock Holding History

Victory Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
25,008
+215
+0.9% +$1.43K ﹤0.01% 2302
2026
Q1 		$180K Buy
24,793
+9,072
+58% +$118K ﹤0.01% 2208
2025
Q4 		$267K Buy
15,721
+1,089
+7% +$11.1K ﹤0.01% 2136
2025
Q3 		$107K Sell
14,632
-45
-0.3% -$364 ﹤0.01% 2289
2025
Q2 		$95.4K Sell
14,677
-145
-1% -$958 ﹤0.01% 2328
2025
Q1 		$120K Buy
14,822
+276
+2% +$3.02K ﹤0.01% 2292
2024
Q4 		$180K Buy
14,546
+2,073
+17% +$27.7K ﹤0.01% 2258
2024
Q3 		$102K Buy
12,473
+8
+0.1% +$48 ﹤0.01% 2320
2024
Q2 		$62.2K Buy
12,465
+883
+8% +$5.04K ﹤0.01% 2345
2024
Q1 		$71.5K Buy
+11,582
New +$58K ﹤0.01% 2338

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Victory Capital Management's WVE Position: Q2 2026 in Review

Victory Capital Management increased its Wave Life Sciences (WVE) stake by 0.87% in Q2 2026, buying an estimated $1.43K and bringing the position to 25,008 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

Victory Capital Management first reported a position in WVE in Q1 2024 and has held it in 10 quarters since. The position peaked at $267K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Victory Capital Management held 25,008 shares of Wave Life Sciences worth $145K as of Q2 2026.
  • Victory Capital Management bought 215 Wave Life Sciences shares in Q2 2026, an estimated $1.43K.
  • Wave Life Sciences made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2302 holding.
  • Victory Capital Management first reported a position in Wave Life Sciences in Q1 2024 and has held it in 10 quarters since.
  • Victory Capital Management's Wave Life Sciences position peaked at $267K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.